Lipoprotein(a) promotes smooth muscle cell proliferation and dedifferentiation in atherosclerotic lesions of human apo(a) transgenic rabbits

American Journal of Pathology

Volumn 160, Issue 1, 2002, Pages 227-236

  Ichikawa, Tomonaga ^a   Unoki, Hiroyuki ^a   Sun, Huijun ^a   Shimoyamada, Hiroaki ^a   Marcovina, Santica ^b   Shikama, Hisataka ^c   Watanabe, Teruo ^d   Fan, Jianglin ^a  

^a UNIVERSITY OF TSUKUBA   (Japan)

^b UNIVERSITY OF WASHINGTON   (United States)

^c ASTELLAS PHARMA INC   (Japan)

^d SAGA UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

APOLIPOPROTEIN A; BINDING PROTEIN; LIPOPROTEIN; MONOCLONAL ANTIBODY; MYOSIN HEAVY CHAIN; PLASMINOGEN ACTIVATOR INHIBITOR;

ANIMAL CELL; AORTA; ARTICLE; ATHEROSCLEROSIS; CAROTID ARTERY; CELL DIFFERENTIATION; CELL PROLIFERATION; CHOLESTEROL DIET; CONTROLLED STUDY; CORONARY ARTERY; FEMALE; ILIAC ARTERY; IMMUNOHISTOCHEMISTRY; MALE; MORPHOMETRICS; NONHUMAN; PHENOTYPE; PRIORITY JOURNAL; RABBIT; SMOOTH MUSCLE FIBER; TRANSGENE;

EID: 0036141412     PISSN: 00029440     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0002-9440(10)64366-0     Document Type: Article

References (40)

1. The mysteries of lipoprotein(a)
2. Lipoprotein (a)
3. A new serum type system in man - The Lp(a) system
4. Atherothrombogenicity of lipoprotein(a): The debate
5. Lipoprotein (a) and coronary heart disease
6. Epidemiology of Lp(a) lipoprotein: Its role in atherosclerotic/thrombotic disease
7. A prospective study of lipoprotein(a) and the risk of myocardial infarction
8. Lipoprotein(a) in coronary heart disease. Is it a risk factor after all?
9. Detection and quantification of lipoprotein(a) in the arterial wall of 107 coronary bypass patients
10. Immunostaining of human autopsy aortas with antibodies to modified apolipoprotein B and apoprotein(a)
11. cDNA sequence of human apolipoprotein(a) is homologous to plasminogen
12. Partial amino acid sequence of apolipoprotein(a) shows that it is homologous to plasminogen
13. Inhibition of fibrinolysis by lipoprotein(a)
14. Proliferation of human smooth muscle cells promoted by lipoprotein(a)
15. Activation of transforming growth factor-beta is inhibited in transgenic apolipoprotein(a) mice
16. Transforming growth factor-beta: The key to understanding lipoprotein(a)?
17. Atherogenesis in transgenic mice expressing human apolipoprotein(a)
18. The apolipoprotein(a) gene is regulated by sex hormones and acute-phase inducers in YAC transgenic mice
19. Transgenic mice expressing a human apolipoprotein[a] allele
20. Reconstitution of lipoprotein(a) by infusion of human low density lipoprotein into transgenic mice expressing human apolipoprotein(a)
21. Human apolipoprotein A-1 prevents atherosclerosis associated with apolipoprotein[a] in transgenic mice
22. Modification of apolipoprotein(a) lysine binding site reduces atherosclerosis in transgenic mice
23. Relative contributions of apolipoprotein (a) and apolipoprotein-B to the development of fatty lesions in the proximal aorta of mice
24. Low density lipoprotein receptor-negative mice expressing human apolipoprotein B-100 develop complex atherosclerotic lesions on a chow diet: No accentuation by apolipoprotein (a)
25. Assembly of lipoprotein (a) in transgenic rabbits expressing human apolipoprotein (a)
26. Transgenic rabbits expressing human apolipoprotein(a) develop more extensive atherosclerotic lesions in response to a cholesterolrich diet
27. Effect of the number of apolipoprotein(a) kringle 4 domains on immunochemical measurements of lipoprotein(a)
28. Defects of the LDL receptor in WHHL transgenic rabbits lead to a marked accumulation of plasma lipoprotein[a]
29. Regression of atherosclerosis in normotensive and hypertensive rabbits. A quantitative analysis of cholesterol-induced aortic and coronary lesions with an image-processing system
30. Human smooth muscle myosin heavy chain isoforms as molecular markers for vascular development and atherosclerosis
31. Lipid lowering promotes accumulation of mature smooth muscle cells expressing smooth muscle myosin heavy chain isoforms in rabbit atheroma
32. BTEB2, a Kruppel-like transcription factor, regulates expression of the SMemb/nonmuscle myosin heavy chain B (SMemb/NMHC-B) gene
33. Isolation of apolipoprotein(a) from lipoprotein(a)
34. Antifibrinolytic effect of recombinant apolipoprotein(a) in vitro is primarily because of attenuation of tPA-mediated Glu-plasminogen activation
35. Increased expression of apolipoprotein E in transgenic rabbits results in reduced levels of very low density lipoproteins and an accumulation of low density lipoproteins in plasma
36. Estradiol inhibits leukocyte adhesion and transendothelial migration in rabbits in vivo: Possible mechanisms for gender differences in atherosclerosis
37. Conditioned medium from HepG2 cells transfected with human apolipoprotein(a) gene stimulates growth of human vascular smooth muscle cells: Effects of overexpression of human apolipoprotein(a) gene
38. Lipoprotein (a) regulates plasminogen activator inhibitor-1 expression in endothelial cells. A potential mechanism in thrombogenesis
39. The association between serum Lp(a) concentrations and angiographically assessed coronary atherosclerosis. Dependence on serum LDL levels
40. Relation of serum lipoprotein(a) concentration and apolipoprotein(a) phenotype to coronary heart disease in patients with familial hypercholesterolemia